A cross-sectional observational study to identify the current status of shared decision making and factors influencing decision making of drug treatment among gynecological cancer patients and health care providers
Not Applicable
- Conditions
- Gynecological cancer (uterine cancer, ovarian cancer/fallopian tube cancer)D005833
- Registration Number
- JPRN-jRCT1040220088
- Lead Sponsor
- Kitano Hiromi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 590
Inclusion Criteria
- Agreed web questionnaire survey.
- 18 year and older.
- Live in Japan.
- Received chemotherapy for uterine cancer, ovarian cancer, or fallopian tube cancer.
- Agreed web questionnaire survey.
- Doctors, nurses, or pharmacists who are engaged in drug treatment for gynecological cancer.
Exclusion Criteria
- Have families engaged in pharmatheutical/survey/marketing company or health care.
- Have double cancer.
- Doctors with less than 5 years of experience as a doctor (including training period).
- Nurses and pharmacists with less than 1 year of experience.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method